BDBM247371 US9447092, 1

SMILES Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1

InChI Key InChIKey=AKJBLKUZXRMECW-UHFFFAOYSA-N

Data  8 IC50  8 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 16 hits for monomerid = 247371   

TargetAurora kinase A(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataIC50:  38nMAssay Description:Myc-tagged Aurora A was transfected in Hela cells using Lipofectamine LTX in 24 well plates, and 24 hours after transfection, cells were treated with...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCytochrome P450 3A4(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP isozymes was determined using a mixture of probe substrates. The samples were incubated for 10 minutes followed by protein precipit...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetAurora kinase A(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataKd:  7.5nMAssay Description:The kinase selectivity was assessed by profiling Example 1 in a 442-kinase panel (386 non-mutant kinases) at a concentration of 1 μM using the K...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetAurora kinase B(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataKd:  48nMAssay Description:The kinase selectivity was assessed by profiling Example 1 in a 442-kinase panel (386 non-mutant kinases) at a concentration of 1 μM using the K...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataKd:  6.20nMAssay Description:The kinase selectivity was assessed by profiling Example 1 in a 442-kinase panel (386 non-mutant kinases) at a concentration of 1 μM using the K...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [D835H](Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataKd:  11nMAssay Description:The kinase selectivity was assessed by profiling Example 1 in a 442-kinase panel (386 non-mutant kinases) at a concentration of 1 μM using the K...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [D835Y](Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataKd:  14nMAssay Description:The kinase selectivity was assessed by profiling Example 1 in a 442-kinase panel (386 non-mutant kinases) at a concentration of 1 μM using the K...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [K663Q](Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataKd:  5.10nMAssay Description:The kinase selectivity was assessed by profiling Example 1 in a 442-kinase panel (386 non-mutant kinases) at a concentration of 1 μM using the K...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [N841I](Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataKd:  16nMAssay Description:The kinase selectivity was assessed by profiling Example 1 in a 442-kinase panel (386 non-mutant kinases) at a concentration of 1 μM using the K...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [R834Q](Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataKd:  110nMAssay Description:The kinase selectivity was assessed by profiling Example 1 in a 442-kinase panel (386 non-mutant kinases) at a concentration of 1 μM using the K...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCytochrome P450 1A2(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP isozymes was determined using a mixture of probe substrates. The samples were incubated for 10 minutes followed by protein precipit...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCytochrome P450 2A6(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP isozymes was determined using a mixture of probe substrates. The samples were incubated for 10 minutes followed by protein precipit...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCytochrome P450 2C9(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataIC50:  30nMAssay Description:Inhibition of CYP isozymes was determined using a mixture of probe substrates. The samples were incubated for 10 minutes followed by protein precipit...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCytochrome P450 2C19(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataIC50:  30nMAssay Description:Inhibition of CYP isozymes was determined using a mixture of probe substrates. The samples were incubated for 10 minutes followed by protein precipit...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCytochrome P450 2D6(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataIC50:  30nMAssay Description:Inhibition of CYP isozymes was determined using a mixture of probe substrates. The samples were incubated for 10 minutes followed by protein precipit...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM247371(US9447092, 1)
Affinity DataIC50: >2.50E+4nMAssay Description:All hERG percentage inhibitions at 10 uM compound concentration were determined by Millipore in a high-throughput cell-based electrophysiology assay ...More data for this Ligand-Target Pair
In DepthDetails US Patent